CymaBay Therapeutics, Inc. Annual Interest Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
CymaBay Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2023.
  • CymaBay Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2023 was $5.08M, a 24.7% increase year-over-year.
  • CymaBay Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2023 was $18.9M, a 27.1% increase year-over-year.
  • CymaBay Therapeutics, Inc. annual Interest Expense for 2023 was $18.9M, a 27.1% increase from 2022.
  • CymaBay Therapeutics, Inc. annual Interest Expense for 2022 was $14.9M, a 477% increase from 2021.
  • CymaBay Therapeutics, Inc. annual Interest Expense for 2021 was $2.58M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $18.9M +$4.04M +27.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $14.9M +$12.3M +477% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $2.58M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2018 $336K -$744K -68.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $1.08M -$257K -19.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 $1.34M +$424K +46.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $913K +$158K +20.9% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-23
2014 $755K -$67K -8.15% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 $822K -$19K -2.26% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-23
2012 $841K Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.